This factsheet provides an overview of the evidence on digital treatments for addiction, such as digital therapeutics, mobile apps, web-based platforms, telehealth services, and emerging digital health forums. It outlines important considerations for healthcare professionals to keep in mind when incorporating these treatments into patient care plans.

This factsheet highlights how establishing structured, evidence-based care pathways for treating alcohol use disorder (AUD) can help Certified Community Behavioral Health Clinics (CCBHCs) expand access to medications for AUD. It explores the benefits of implementing these protocols and shares recommendations for evidence-based best practices. 

This toolkit outlines the vital role of social workers supporting patients in hospitals with alcohol use disorder. It highlights how to conduct screenings, provide education on safe drinking guidelines and sustainable treatment options, coordinate aftercare, and facilitate care team communication, as well as the importance of engaging support networks. 

This factsheet offers an overview of nationally available recovery groups, also known as mutual aid, mutual help, or self-help groups, that support people seeking recovery or already in long-term recovery, along with their families and loved ones.

This toolkit highlights the vital role nurses play in the screening, assessment, and treatment of patients with alcohol use disorder (AUD) and alcohol withdrawal syndrome in hospital settings. It offers evidence-based guidance on screening tools and treatment strategies, tailored to the scope of responsibilities for nurses. 

This infographic summarizes various biomarker tests for detecting recent, ongoing, or chronic alcohol use. It compares both alcohol-specific and non-specific biomarkers based on their detection windows, accuracy, cost, and clinical limitations to aid in selecting appropriate testing methods.

This factsheet summarizes the current evidence on the safety of medications for alcohol use disorder during pregnancy and breastfeeding, focusing on naltrexone, acamprosate, and disulfiram. It outlines treatment gaps in prenatal care, clinical considerations for risk-benefit assessment, and available safety data to inform care for pregnant and postpartum women with AUD.

This factsheet discusses the Sinclair Method, an off-label approach to treating alcohol use disorder that involves taking naltrexone on drinking days to gradually reduce alcohol consumption. It outlines how the method works, patient eligibility, protocol guidance, and comparisons to other naltrexone dosing strategies.

This factsheet provides a comprehensive overview of how to screen for alcohol use disorder, including what screening tools are validated for adults, adolescents, pregnant women, and older adults as well as special considerations for screening each of these populations.

This factsheet explores the costs of treating alcohol use disorder (AUD) using pharmacologic and non-pharmacologic treatment approaches, comparing the expenses to the direct, indirect, and societal costs of untreated AUD.